Compare
Compare archived captures
This view highlights text differences between two archived captures. It does not interpret meaning or provide guidance.
Descriptive changes only
This comparison highlights text changes between archived captures. It does not interpret the change or provide medical advice. For up-to-date recommendations, always consult the official source website.
Need to cite this comparison? See /cite.
Earlier capture
Use of foreign reviews and decisions - Canada.ca
Apr 18, 2025
legacy-hc-2025-04-21
ID 256275
Later capture
Use of foreign reviews and decisions - Canada.ca
Jan 2, 2026
hc-20260101
ID 428611
updated2 sections changed
2 sections changed0 added0 removed+0 / -3 linesChange ratio: 10%
--- +++ @@ -1,6 +1,4 @@ Use of foreign reviews and decisions-From:-Health Canada This project is focussed on achieving 2 distinct goals. These are to: standardize the use of reviews conducted by other Regulatory Agencies (foreign reviews) to gain efficiencies in our review of submissions for prescription drugs for human use allow authorizations for certain drugs that meet an unmet medical need to be based on a foreign decision (This would be for certain human and veterinary drugs that have been approved by a listed foreign regulator and that have adequate post-market experience in that jurisdiction.)@@ -12,5 +10,4 @@ publishing final regulations Canadians will have the opportunity to comment on the regulatory proposal during a public comment period, expected in spring 2020. Page details-Date modified: 2019-07-17